EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Therapy adherence after interdisciplinary tumour board discussion is associated with improved outcome in soft tissue sarcoma: A Charité Comprehensive Cancer Centre analysis

Annika Strönisch iD, Daniel Rau, Silvan Wittenberg, David Kaul, Georgios Koulaxouzidis, Robert Öllinger, Maximilian von Laffert, Armin Jarosch, Frederik Schäfer, Ulrich Keilholz, Lars Bullinger, Sven Märdian und 2 weitere

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Annika Strönisch und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berli…. Hauptthemen laut MEDLINE: Sarcoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Centralising soft tissue sarcoma (STS) treatment in expert centres and implementing comprehensive therapy concepts through interdisciplinary tumour boards (ITB) has led to significant treatment progress. However, our knowledge on the implementation of the ITB recommendations and its impact on patient outcome is limited. In this retrospective analysis, we examined a cohort of 222 adult patients (pts) with primary STS who were presented to the ITB of the Charité Comprehensive Cancer Centre between 2015 and 2020. In localised disease ( n = 188), resection was recommended in 71% ( n = 134) of pts. The treatment modalities chemotherapy with or without regional deep hyperthermia, and radiotherapy were recommended in 37% ( n = 69), 26% ( n = 48) and 52% ( n = 97), respectively. Complex multidisciplinary concepts were established in 29% ( n = 54) including ≥3 treatment modalities. Only partial adherence, either by choice of patient or treating physician, was associated with a higher risk of both progression (HR 4.0 95%‐CI 1.6–9.7 p < .01) and mortality (HR 5.3 95%‐CI 1.7–16.4 p < .01). Pts inable to follow the ITB recommendations due to complications or rapid progression showed a high‐risk profile with increased mortality and progression rates (HR 18.1 95%‐CI 8.5–38.2 p < .001; HR 21.5 95%‐CI 8.5–54.7 p < .001). To our knowledge, this represents the first German Comprehensive Cancer Centre analysis of therapy adherence in STS. It provides further real‐world evidence that full adherence to ITB recommendations and the ability to adhere to them are of prognostic value for patient outcome and underlines the importance of interdisciplinary decision‐making and treatment planning for STS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultCombined Modality TherapyTreatment OutcomeAged, 80 and overYoung AdultPatient Care Team

Stichwörter der Autor:innen

interdisciplinary tumour boardsoft tissue sarcomatherapy adherence

Autor:innen und Institutionen

  • Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Centre for Musculoskeletal Surgery, Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Department of Radiation Oncology, Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Department of Plastic, Aesthetic and Reconstructive Surgery, Congregational Hospital Linz, Sisters of Mercy, Linz, Austria.
  • Department of Surgery, Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Institute of Pathology, University Hospital Leipzig, Leipzig, Germany.

ORCID-Profile: Annika Strönisch

Zitieren

APA

Strönisch, A., Rau, D., Wittenberg, S., Kaul, D., Koulaxouzidis, G., Öllinger, R., von Laffert, M., Jarosch, A., Schäfer, F., Keilholz, U., Bullinger, L., Märdian, S., Striefler, J., & Flörcken, A. (2025). Therapy adherence after interdisciplinary tumour board discussion is associated with improved outcome in soft tissue sarcoma: A Charité Comprehensive Cancer Centre analysis. International Journal of Cancer. https://doi.org/10.1002/ijc.35201

Vancouver

Strönisch A, Rau D, Wittenberg S, Kaul D, Koulaxouzidis G, Öllinger R, et al. Therapy adherence after interdisciplinary tumour board discussion is associated with improved outcome in soft tissue sarcoma: A Charité Comprehensive Cancer Centre analysis. International Journal of Cancer. 2025. doi:10.1002/ijc.35201

BibTeX
@article{Strnisch2025,
  author = {Strönisch, Annika and Rau, Daniel and Wittenberg, Silvan and Kaul, David and Koulaxouzidis, Georgios and Öllinger, Robert and von Laffert, Maximilian and Jarosch, Armin and Schäfer, Frederik and Keilholz, Ulrich and Bullinger, Lars and Märdian, Sven and Striefler, Jana and Flörcken, Anne},
  title = {Therapy adherence after interdisciplinary tumour board discussion is associated with improved outcome in soft tissue sarcoma: A Charité Comprehensive Cancer Centre analysis},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35201}
}
Kostenlos starten →